期刊文献+

顶空毛细管气相色谱法测定来曲唑原料药中有机溶剂残留量 被引量:14

Determination of Residual Organic Solvents in Letrozole by Headspace Capillary Gas Chromatography
原文传递
导出
摘要 目的:建立顶空毛细管气相色谱法测定来曲唑原料药中的三氯甲烷、乙醇、丙酮、乙酸乙酯、N,N-二甲基甲酰胺(DMF)及异丙醇的残留量。方法:以HP-5毛细管柱为色谱柱、二甲基亚砜为溶剂,选择顶空进样法分别测定来曲唑中间品中的三氯甲烷、乙醇、丙酮、乙酸乙酯残留量及来曲唑成品中的DMF和异丙醇残留量。其中,三氯甲烷选用电子捕获检测器,其余有机溶剂选用氢火焰离子化检测器。结果:6种有机溶剂实现基线分离,三氯甲烷、乙醇、丙酮、乙酸乙酯、DMF、异丙醇的线性范围分别为1.028~10.28mg·L-(1r=0.9999)、94.68~946.8mg·L-(1r=0.9997)、94.64~946.4mg·L-(1r=0.9997)、110.64~1106.4mg·L-1(r=0.9997)、15.12~151.2mg·L-(1r=0.9996)、116.48~1164.8mg·L-(1r=0.9995);方法平均回收率为97%~102%;最低检出浓度为20~90μg·L-1;3批中间体和成品样品中均未检出6种有机溶剂,符合《中国药典》要求。结论:该方法简便灵敏,结果准确可靠,能较好地进行来曲唑原料药中有机溶剂残留量的检测。 OBJECTIVE: To establish headspace capillary gas chromatography for the content determination of residual solvents in letrozole, such as chloroform, ethanol, acetone, ethyl acetate, DMF and isopropanol. METHODS: Dissolved in dimethyl sulfoxide, chloroform, ethanol, acetone, ethyl acetate, DMF and isopropanol in letrozole were determined by headspace gas chromatography with HP-5 capillary gas chromatography. ECD was applied for chloroform, while FID was applied for the other residual solvents. RESULTS: The liner ranges of chloroform, ethanol, acetone, ethyl acetate, DMF and isopropanol were 1.028~10.28 mg·L-1(r=0.999 9), 94.68~946.8 mg·L-1 (r=0.999 7), 94.64~946.4 mg·L-1(r=0.999 7), 110.64~1 106.4 mg·L-1(r=0.999 7), 15.12~151.2 mg·L-1(r=0.999 6), 116.48~1 164.8 mg·L-1(r=0.999 5), respectively. The average recoveries of the residual organic solvents ranged from 97% to 102%. The detection limits were 20~90 μg·L-1. The residual levels of the six organic solvents in three batches of samples were all up to the standard stipulated in Chinese Pharmacopeia. CONCLUSIONS: The method is simple, sensitive, accurate and reliable for the content determination of residual organic solvents in letrozole.
机构地区 郑州大学药学院
出处 《中国药房》 CAS CSCD 北大核心 2010年第17期1601-1603,共3页 China Pharmacy
关键词 来曲唑 有机溶剂残留量 毛细管气相色谱法 顶空进样 Letrozole Residual organic solvents Capillary gas chromatography Headspace injection
  • 相关文献

参考文献7

二级参考文献15

  • 1周海钧,金少鸿.人用药品注册技术规范国际协调会(ICH)——质量的技术要求[J].中国药学杂志,1996,31(11):694-697. 被引量:18
  • 2Mouridsen H, C, ershanovich M, Sun Y, et al. Superior eefficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer:, results of a phase Ⅲ study of the international letrozole breast cancer group [J].
  • 3Robertson J, Buzdar A, Howell A, et al. Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer[J]. Breast Cancer Res Treat, 1999,58 (2):157-162.
  • 4Dombemowsky P, Smith I, Falkson G, et al. Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate[J]. J Clin Oncol, 19
  • 5Gershanovich M, Chaudri H, Campos D, et al. Letrozole, a new oral aromatase inhibitor:, randomized trial comparing 2.5mg daily, 0.5ug daily and aminoglutethimide in postmenopausal women with advanced breast cancer[J]. Ann Oncol, 1998,9(6): 639-645.
  • 6Ellis M J, Coop A, Singh B, et al. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB- 1 - and/or ErbB2- positive, estrogen receptor-positive primary breast cancer: evidence from a phase Ⅲ randomized trial[J]. J Clin Oncol,
  • 7Brodil ALu Q Liu,et al Preclinical studies using the intratumoral aromatase for postmenopausal breast cancer .Oncology,1998,12(3Suppl5):S36.
  • 8江泽飞.乳癌内分泌治疗的新思路和新策略[A]..第八届全国肿瘤化疗和药理学术会议[C].,2003年..
  • 9Lipton A, Demers LM, Harvey HA. Letrozole (CGS 20267):a phase I study of a new potent oral aromatase inhibitor of brease Cancer. Cancer, 1995, 75:2132.
  • 10Harvey HA. Emerging role of aromatase inhibitors in the treat ment of brease cancer. Oncology ,1998,12(3 Suppl 5):S32.

共引文献43

同被引文献92

引证文献14

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部